XTX Topco Ltd Buys Shares of 114,898 Bausch Health Companies Inc. (NYSE:BHC)

XTX Topco Ltd purchased a new stake in Bausch Health Companies Inc. (NYSE:BHC - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 114,898 shares of the company's stock, valued at approximately $938,000.

A number of other hedge funds have also modified their holdings of BHC. Headlands Technologies LLC acquired a new position in Bausch Health Companies during the 2nd quarter worth $35,000. MQS Management LLC acquired a new stake in shares of Bausch Health Companies in the 2nd quarter valued at $71,000. Certuity LLC purchased a new stake in shares of Bausch Health Companies during the 2nd quarter worth $75,000. Bfsg LLC grew its stake in shares of Bausch Health Companies by 46.7% during the second quarter. Bfsg LLC now owns 11,450 shares of the company's stock worth $80,000 after purchasing an additional 3,643 shares in the last quarter. Finally, Kendall Capital Management acquired a new stake in Bausch Health Companies in the second quarter valued at $87,000. 78.65% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

BHC has been the subject of several recent analyst reports. Evercore ISI upgraded Bausch Health Companies to a "hold" rating in a research note on Tuesday, October 15th. StockNews.com upgraded shares of Bausch Health Companies from a "hold" rating to a "buy" rating in a research note on Friday, October 25th. Finally, Royal Bank of Canada lifted their target price on Bausch Health Companies from $10.00 to $11.00 and gave the stock a "sector perform" rating in a research report on Friday, November 1st. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Bausch Health Companies currently has an average rating of "Hold" and an average price target of $7.75.

Bausch Health Companies Stock Down 8.8 %

NYSE BHC traded down $0.74 during trading hours on Wednesday, hitting $7.59. 4,776,940 shares of the stock were exchanged, compared to its average volume of 2,796,850. The stock has a 50-day moving average of $8.41 and a 200 day moving average of $7.22. The company has a market cap of $2.74 billion, a price-to-earnings ratio of -15.79 and a beta of 0.69. Bausch Health Companies Inc. has a 12-month low of $3.96 and a 12-month high of $11.46.

Bausch Health Companies (NYSE:BHC - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.12 EPS for the quarter, topping the consensus estimate of $1.02 by $0.10. The company had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.42 billion. Bausch Health Companies had a negative net margin of 1.88% and a negative return on equity of 755.86%. The business's revenue was up 12.2% on a year-over-year basis. During the same period in the previous year, the firm earned $1.03 EPS. On average, equities research analysts expect that Bausch Health Companies Inc. will post 3.74 earnings per share for the current year.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.